- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03009370
The Effect of the Ovarian Reserve on the Recurrent Pregnancy Loss
Study Overview
Status
Conditions
Detailed Description
This study will be conducted at the gynecology and infertility department of Kanuni Sultan Süleyman Training and Research Hospital from 2016 to 2017. The approval of the local Institutional Review Board (KAEK/2016.22.31) was obtained in June 2016 and informed consents of all subjects have been prepared. RM is defined as three or more pregnancy losses at <20 weeks of gestation or fetal weight <500 g. Women with history of RM for whom routine workup for RM (chromosomal analyses of both partners; levels of prolactin and TSH; anticardiolipin antibody, lupus anticoagulant, antinuclear antibody, and coagulation studies; and pelvic ultrasonography) is negative are assigned to the RM group. The control group consists of healthy women with no history of RM who are seeking contraception in the center's family planning unit. To keep the power of the study at 80% with an alpha-level of 0.05, a sample size of minumum 60 patients in each group was required.
Demographic data (age,gravidity,parity,pregnancy loss,bmı) ovarian reserve parameters(AMH,FSH,LH,E2,AFC) will be recorded and then two groups will be compared.
Data will be analyzed with the use of medcalc version 16.4.8 by Gökhan Yıldırım. Mean,median,SD,lowest and highest frequency ,and ratio values are used at statistical complementary of data .Quantitative data will be analyzed with the use of the Student t test and the Mann-Whitney U test. A chisquare test will be used for analyses of qualitative data
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Gonca Yetkin Yıldırım, MD
- Phone Number: +90 5323532205
- Email: goncayetkinyildirim@gmail.com
Study Contact Backup
- Name: Nadiye Köroğlu, MD
- Phone Number: +90 5058065348
- Email: nadiye_dugan@hotmail.com
Study Locations
-
-
-
Istanbul, Turkey, 34325
- Recruiting
- Kanuni Sultan Süleyman Eğitim ve Araştırma Hastanesi
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Women with RM between 20-40 years old
Exclusion Criteria:
- Anovulation or PCOS
- Presence of endometrosis by laparoscopy or ultrasonography
- History of ovarian surgery
- Tobacco use
- Systemic chemotherapy
- Pelvic irradition
- Genetic abnormalities
- Irregular menstruel cycle
- family history of premature ovarian failure
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Recurrent miscarriage
RM is defined as three or more pregnancy losses at< 20 weeks of gestation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The effect of the ovarian reserve on the recurrent pregnancy loss
Time Frame: up to 6 months
|
Venous blood samples will be taken from the antecubital regions of all patients between 8:00 a.m and 9:00 a.m during the early follicular phase (days 2-4) of the menstrual cycle .Serum samples will be stored at -80C and assayed for FSH,LH,E2 and AMH .FSH levels are analyzed by means of an electrochemiluminescence method .The normal range for FSH is 2.5-10 U/L at the early follicular phase.
Serum AMH levels will be measured with the use of a human ELİSA kit .
The normal range for this assay is 0.05-1.5 ng/ml.In the same morning that the blood tests are performed , the total number of antral follicles measuring 2-10 mm in diameter are evaluated by the operator.A 7.5 -MHz transvaginal probe is used in all examinations.Data will be analyzed with the use of medcalc.
|
up to 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Ovarian reserve tests can be used for the diagnosis of the cause of recurrent pregnancy loss
Time Frame: up to 6 months
|
FSH,LH,E2,AMH assesment of at least 86 patients will be analyzed with the use of medcalc .
Unıts of measure of FSH,LH,E2 levels are assesed by U/L.
The normal range of AMH level is 0.05-1.5ng/ml.
Mean ,median ,SD, lowest and highest frequency ,and ratio values are used at statistical complemantary data.Quantitative data are analyzed with the use of the student -t test and Mann-Whitney U test
|
up to 6 months
|
Collaborators and Investigators
Investigators
- Study Director: Gonca Yetkin Yıdırım, MD, Saglik Bilimleri Universitesi
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- KanuniSSSTRH
Plan for Individual participant data (IPD)
Study Data/Documents
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Miscarriage, Recurrent
-
Fudan UniversityUnknown
-
Nanjing UniversityCompletedUnexplained Recurrent Miscarriage and Recurrent Implantation FailureChina
-
Rigshospitalet, DenmarkThe Ministry of Science, Technology and Innovation, DenmarkCompletedSecondary Recurrent MiscarriageDenmark
-
Assiut UniversityCompleted
-
UMC UtrechtCompleted
-
Woman's Health University Hospital, EgyptTerminatedRecurrent Pregnancy LossesEgypt
-
National Cheng-Kung University HospitalMinistry of Science and Technology, TaiwanCompletedCare in Women With History of Recurrent Miscarriage
-
Peking University Third HospitalUnknownInfertility | Recurrent Miscarriage | Recurrent Implantation FailureChina
-
Ain Shams UniversityCompleted
-
Omar Mamdouh ShaabanCompleted